HIV

The AJMC® HIV compendium is a comprehensive resource for clinical news and expert insights for the condition, including disparities in care, prevention of infection among at-risk groups, and the importance of viral suppression.

Latest News

Illicit drugs | Image credit: Stanislau_V - stock.adobe.com
SDOH Domains at Risk Correlated With Substance Use in People With HIV

May 2nd 2025

Correlation to social drivers of health (SDOH) had an important correlation with polysubstance use.

HIV | Image credit: reddish - stock.adobe.com
Family Dynamics, Mental Health Influence Adherence to ART

April 29th 2025

Richard Hughes IV, JD, MPH
What's at Stake as Oral Arguments Are Presented in the Braidwood Case? Q&A With Richard Hughes IV

April 21st 2025

Women with HIV | Image credit: LIGHTFIELD STUDIOS - stock.adobe.com
Poor Well-Being in HIV Associated With SDOH Adversities

April 16th 2025

Money | Image credit: Stillfx - stock.adobe.com
Freeze in International Funding Could Significantly Reverse Progress in HIV Treatment

April 3rd 2025

Clarifying USPSTF Recommendations for HIV Pre-Exposure Prophylaxis (PrEP)

This discussion focuses on how to address barriers and disparities as obstacles to using PrEP, with a focus on USPSTF PrEP guidelines and ACA Part 47 for payers and providers.

This multi-stakeholder roundtable panel discussion will focus on how to address barriers and disparities as obstacles to the use of PrEP, with a focus on increased understanding and education around US Preventive Services Task Force (USPSTF) PrEP guidelines and Affordable Care Act Part 47 for payers and providers.
Continuing Medical Education
View All
May 2nd 2025

Navigating the HIV Treatment Frontier: Equipping Managed Care Professionals With Strategies for Innovation, Access, and Adherence

1.5 Credits / HIV/AIDS, Infectious Diseases

More News

Researchers Say They Can Now Accurately Measure HIV Reservoirs
January 30th 2019

Researchers Say They Can Now Accurately Measure HIV Reservoirs

Jaime Rosenberg
Being able to accurately measure HIV reservoirs that remain in the body even during viral suppression is the first step to being able to destroy these reservoirs and, potentially, cure the infection. Researchers say they've created a new technique that will allow them to do so.
Lung Disease From Smoking Marijuana More Likely in Men With HIV
January 26th 2019

Lung Disease From Smoking Marijuana More Likely in Men With HIV

Jaime Rosenberg
Men living with HIV are more likely to develop lung disease from long-term marijuana smoking compared with uninfected men.
HIV, Vaccine Refusal, Delays Among Greatest Threats to Global Health, Says WHO
January 22nd 2019

HIV, Vaccine Refusal, Delays Among Greatest Threats to Global Health, Says WHO

Jaime Rosenberg
The organization's list of 10 health challenges include both environmental and medical challenges they say demand attention from the World Health Organization (WHO) and health partners in 2019.
NIH Researchers Say the Science Is Clear: Undetectable Equals Untransmittable in HIV
January 16th 2019

NIH Researchers Say the Science Is Clear: Undetectable Equals Untransmittable in HIV

Jaime Rosenberg
Researchers from the National Institutes of Health (NIH)’s National Institute of Allergy and Infectious Diseases reviewed clinical trials and cohort studies validating the concept that people living with HIV who have achieved viral suppression can not sexually transmit HIV.
Damaged Immune Receptor Could Lead to More Severe Comorbidities in HIV, Study Finds
January 14th 2019

Damaged Immune Receptor Could Lead to More Severe Comorbidities in HIV, Study Finds

Samantha DiGrande
While treatment for HIV has made tremendous strides over the past few decades, many patients with the infection still struggle with comorbidities such as chronic inflammation, diabetes, and cardiovascular problems, among others. In a recent study, researchers at Michigan State University sought to understand why patients with HIV develop such complications.
Following Discrimination Allegations, Insurer Will Stop Denying Coverage Based on PrEP Usage
January 11th 2019

Following Discrimination Allegations, Insurer Will Stop Denying Coverage Based on PrEP Usage

Jaime Rosenberg
Mutual of Omaha has agreed to no longer deny life insurance and long-term insurance to people using Truvada for HIV prevention following allegations of discrimination in 2 separate settlements.
State Data Show Racial/Ethnic Disparities in HIV, Syphilis Diagnoses Among MSM
January 8th 2019

State Data Show Racial/Ethnic Disparities in HIV, Syphilis Diagnoses Among MSM

Jaime Rosenberg
Using state-level surveillance data of reported HIV and syphilis cases among men who have sex with men (MSM), researchers found a widely disparate impact of HIV and syphilis among black and Hispanic MSM compared with white MSM.
People Living With HIV Have 2-Fold Risk of Heart Failure
January 5th 2019

People Living With HIV Have 2-Fold Risk of Heart Failure

Jaime Rosenberg
People living with HIV are at a greater risk for incident heart failure, with those with higher viral loads and lower CD4+ T cell counts having the greatest risk.
Study Finds No Decrease in Health-Related QOL Among High-Risk Individuals Starting PrEP for HIV
January 3rd 2019

Study Finds No Decrease in Health-Related QOL Among High-Risk Individuals Starting PrEP for HIV

Jaime Rosenberg
Quality of life (QOL) in at-risk individuals starting pre-exposure prophylaxis (PrEP) for HIV prevention is similar to that in the general population and is maintained over time.
Study Identifies Inverse Relationship Between Minimum Wage, HIV Diagnoses Among Black Men, Women
December 27th 2018

Study Identifies Inverse Relationship Between Minimum Wage, HIV Diagnoses Among Black Men, Women

Jaime Rosenberg
Metropolitan areas with a minimum wage that was $1 higher at baseline had a 27.12% lower rate of newly diagnosed HIV cases among black residents.
Single-Tablet Regimens Produce Better HIV Virologic Response Than Multiple-Tablet Regimens
December 26th 2018

Single-Tablet Regimens Produce Better HIV Virologic Response Than Multiple-Tablet Regimens

Jaime Rosenberg
According to a new study, single-tablet regimens may provide better virologic response and control than multiple-tablet regimens for people living with HIV, likely due to a lower pill burden and, subsequently, better medication adherence.
Diabetes, Cancer Interviews Among Most-Watched Videos of 2018
December 20th 2018

Diabetes, Cancer Interviews Among Most-Watched Videos of 2018

Laura Joszt, MA
Throughout the year, The American Journal of Managed Care® (AJMC®) offered a number of video programs, including Peer Exchange discussions and interviews, on a range of topics. Here are the most-watched videos published by AJMC® in 2018.
Disparities in HIV Diagnoses Persist Among Black Women in the US
December 20th 2018

Disparities in HIV Diagnoses Persist Among Black Women in the US

Jaime Rosenberg
Despite HIV diagnosis rates decreasing among black women as a whole, disparities in diagnosis rates persist among US- and non–US-born black women.
Study Determines Why Patients With HIV Have Higher Rates of Cancer
December 15th 2018

Study Determines Why Patients With HIV Have Higher Rates of Cancer

Alison Rodriguez
After investigating why patients with HIV have higher rates of cancer than the general population, researchers identified how T-cells move and multiply to invade other cells in these patients.
NIH Announces Funding for HIV Treatment, Prevention Research in Vulnerable Southern Counties
December 13th 2018

NIH Announces Funding for HIV Treatment, Prevention Research in Vulnerable Southern Counties

Jaime Rosenberg
The National Institutes of Health (NIH) said that it will fund a series of collaborations with medical research institutions in the region as part of a new initiative that will expand ongoing research at the NIH-funded Centers for AIDS Research, a group of HIV-focused research institutions focused on reducing the burden of HIV domestically and globally.
NIH Commentary Highlights Importance of Engaging Men in HIV Treatment, Prevention
December 7th 2018

NIH Commentary Highlights Importance of Engaging Men in HIV Treatment, Prevention

Jaime Rosenberg
In a new commentary, scientists from the National Institutes of Health (NIH) assert that engaging men in HIV prevention and care is essential for ending the HIV pandemic.
HIV-2 Just as Deadly as HIV-1, but at a Slower Rate
December 6th 2018

HIV-2 Just as Deadly as HIV-1, but at a Slower Rate

Alison Rodriguez
A recent study compared the time to AIDS and mortality and the CD4 T-cell dynamics between HIV-1 and HIV-2, finding that both groups have a high probability of developing and dying from AIDS without antiretroviral treatment.
Disparities in HIV Care Among Hispanic/Latino Men and Women
December 1st 2018

Disparities in HIV Care Among Hispanic/Latino Men and Women

Alison Rodriguez
A new report from the CDC revealed that it is necessary for providers to be aware of the challenges faced by Hispanics/Latinos with diagnosed HIV and to improve access to ancillary services.
Podcast: This Week in Managed Care—CMS Drug Coverage Changes Draw Ire and Other Health News
December 1st 2018

Podcast: This Week in Managed Care—CMS Drug Coverage Changes Draw Ire and Other Health News

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.
Highlighting Progress, Need for Improvement in HIV Epidemic Ahead of World AIDS Day
November 30th 2018

Highlighting Progress, Need for Improvement in HIV Epidemic Ahead of World AIDS Day

Jaime Rosenberg
As the world observes World AIDS Day 2018 on December 1, WalletHub has released an HIV/AIDS report in an effort to increase awareness about the virus.
This Week in Managed Care: November 30, 2018
November 30th 2018

This Week in Managed Care: November 30, 2018

This week, the top managed care news included a CMS plan for changes in drug coverage that brought a wave of criticism; a government task force recommended more people at risk for HIV take pre-exposure prophylaxis, known as PrEP; the American College of Cardiology issued an Expert Consensus Pathway on treatment of patients with type 2 diabetes and atherosclerotic cardiovascular disease.
Top 5 AJMC® Articles of November 2018
November 30th 2018

Top 5 AJMC® Articles of November 2018

Here are the top 5 articles for the month of November.
USPSTF Recommends Clinicians Prescribe HIV PrEP to All High-Risk Patients
November 22nd 2018

USPSTF Recommends Clinicians Prescribe HIV PrEP to All High-Risk Patients

Jaime Rosenberg
The US Preventive Services Task Force (USPSTF) is recommending that clinicians offer the treatment to people at high risk of HIV, which will likely increase access to the treatment for those who need it most.
Cellular Proliferation Drives HIV Persistence During Treatment With ART
November 21st 2018

Cellular Proliferation Drives HIV Persistence During Treatment With ART

Jaime Rosenberg
According to a new study, cellular proliferation generates the majority of infected cells during antiretroviral therapy (ART), suggesting that reducing proliferation can decrease the size of the HIV reservoir and work toward a cure.
Following Release From Incarceration, People Living With HIV Have Higher Mortality Rates Than General Population
November 16th 2018

Following Release From Incarceration, People Living With HIV Have Higher Mortality Rates Than General Population

Alison Rodriguez
Following release from prison or jail, people living with HIV have higher mortality rates than the general population, indicating that resources are needed to identify and treat HIV and other medical needs following release from incarceration in order to reduce mortality.
Provider Stigma Toward HIV Slows Prevention Goals
November 15th 2018

Provider Stigma Toward HIV Slows Prevention Goals

Jaime Rosenberg
As physicians have an essential role in the fight against HIV—leading patients through the care continuum—understanding HIV-related stigma among physicians can inform development of interventions to reduce this stigma and promote positive clinical outcomes.
Advance Care Planning Among Adolescent Patients With HIV Lowers Symptoms, Suffering
November 10th 2018

Advance Care Planning Among Adolescent Patients With HIV Lowers Symptoms, Suffering

Alison Rodriguez
Family-centered pediatric advance care planning increased and maintained agreement about goals of care longitudinally, which lowered adolescents’ physical symptoms and suffering.
Hispanics Living With HIV at Increased Risk of HPV-Related Cancers
November 6th 2018

Hispanics Living With HIV at Increased Risk of HPV-Related Cancers

Jaime Rosenberg
Hispanics living with HIV are at an increased risk of developing cancers caused by the human papillomavirus (HPV) compared to the general Hispanic population, and among people living with HIV, Hispanics are more likely to be diagnosed with cervical and penile cancer.
Researchers Propose Adding Viral Suppression Within 3 Months of HIV Diagnosis to HIV/AIDS Strategy
November 1st 2018

Researchers Propose Adding Viral Suppression Within 3 Months of HIV Diagnosis to HIV/AIDS Strategy

Jaime Rosenberg
Recognizing a need for an outcome indicator for those newly diagnosed with HIV, researchers have proposed including the percentage of newly diagnosed persons achieving viral suppression within 3 months of diagnosis.
Janssen Releases Long-Term AMBER Trial Data Supporting Safety, Efficacy of Symtuza for HIV
October 30th 2018

Janssen Releases Long-Term AMBER Trial Data Supporting Safety, Efficacy of Symtuza for HIV

Jaime Rosenberg
Building on positive 48-week data, Janssen released 96-week data demonstrating high rates of virogolic suppression and tolerability among antiretroviral therapy-naïve adults with HIV-1.
<1
...
192021222324252627
...
32>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo